Comparison of Two Therapeutic Regimens: Methotrexate-Folinic Acid (۸ days) and Weekly Methotrexate in Patients with Low risk Gestational Trophoblastic neoplasia
- سال انتشار: 1397
- محل انتشار: مجله دانشگاه علوم پزشکی کرمان، دوره: 25، شماره: 6
- کد COI اختصاصی: JR_JKMU-25-6_001
- زبان مقاله: انگلیسی
- تعداد مشاهده: 96
نویسندگان
Assistant professor, Fellowship of Gyneco-Oncology, Kerman University of Medical Sciences, Kerman, Iran
MD. Obstetrics & Gynecology, Kerman University of Medical Sciences, Kerman, Iran
چکیده
Background: Methotrexate is used in the treatment of Low-risk Gestational Trophoblastic Neoplasia. The purpose of this study was to compare the therapeutic responses and side effects of two therapeutic methods which were prescribed for patients suffering from Low-risk Gestational Trophoblastic Neoplasia. One method was the daily use of Methotrexate-Folic Acid (for ۸ days) and the other was the weekly use of Methotrexate.Methods:This study is a randomized double-blind clinical trial which was undertaken on ۱۲۲ patients suffering from Low-risk Gestational Trophoblastic Neoplasia, who referred to AfzaliPoor Hospital in Kerman City, Iran. The patients were randomly divided into two groups: one group took Methotrexate-Folic Acid daily for a period of ۸ days (muscular taking of one milligram/kilogram of Methotrexate in days ۱,۳,۵ and ۷; and ۰.۱ milligram/kilogram of Folic Acid in days ۲,۴,۶ and ۸); the other group took the same medication weekly (muscular taking of ۳۰ to ۵۰ milligrams per each square meter of body mass every week).Results: Findings showed that ۹۵% of the patients effectively responded to the ۸-day regimen and ۹۰% responded to weekly regimen. Five percent of the ۸-day regimen group and ۱۰% of the weekly regimen group needed a second treatment. This difference was not significant. Concerning the related side effects, only one patient in the weekly regimen group experienced nausea and vomiting, and one patient experienced neutropenia; while ۴ patients in the ۸-day regimen group experienced nausea and vomiting, one patient had mucositis, ۲ patients had conjunctivitis, two patients experienced neutropenia, and one patient had thrombocytopenia.Conclusions: Considering the related costs, the ۸-day regimen was significantly more economical and affordable than the weekly regimen.کلیدواژه ها
Folic acid, Gestational trophoblastic neoplasia, methotrexateاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.